Table 3.
Mean | SD | Minimum | Maximum | |||
---|---|---|---|---|---|---|
Follow-up TACE region, | ALP | 10.0 | 7.4 | 3.0 | 19.9 | mL/100 mL/min |
no recurrence (n = 15) | PVP | 37.5 | 5.3 | 33.5 | 45.2 | mL/100 mL/min |
HPI | 41.3 | 15.6 | 20.1 | 54.9 | % | |
Follow-up TACE region, | ALP | 39.1 | 10.1 | 22.3 | 61.4 | mL/100 mL/min |
recurrence (n = 17) | PVP | 12.4 | 13.3 | 0.2 | 49.7 | mL/100 mL/min |
HPI | 85.6 | 15.4 | 50.4 | 99.3 | % | |
Follow-up rim region, | ALP | 13.1 | 10.0 | 6.0 | 20.2 | mL/100 mL/min |
no recurrence (n = 15) | PVP | 39.4 | 34.7 | 14.9 | 63.9 | mL/100 mL/min |
HPI | 47.0 | 54.7 | 8.3 | 85.7 | % | |
Follow-up rim region, | ALP | 29.2 | 6.3 | 20.2 | 38.8 | mL/100 mL/min |
recurrence (n = 17) | PVP | 22.3 | 13.1 | 5.8 | 45.6 | mL/100 mL/min |
HPI | 72.7 | 17.5 | 38.1 | 93.2 | % |
SD = standard deviation, ALP = arterial-liver perfusion, PVP = portal-venous perfusion, HPI = hepatic-perfusion index.